Previous 10 | Next 10 |
AIkido Pharma Provides Business Update Drug Research and Development Progressing Well-Capitalized to Further Efforts and Opportunistically Expand Portfolio PR Newswire NEW YORK , April 5, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkid...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 31, 2021 – The emerging psychedelics therapy market has been among the top financial stories of 2021 so far, driven by major legal and regulatory breakthroughs, promising resea...
AIkido Pharma Sponsors Psychedelic Compound Research to Treat PTSD PR Newswire NEW YORK , March 29, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it is sponsoring psychedelic research at the Mount Sin...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 17, 2021 – Canada has become home to some of the most important research and development happening today in the mental health and wellness space. Psychedelic therapy emerged as...
AIkido Pharma Announces Dr. Matt Frieman's Appearance on This Week in Virology Dr. Frieman Discusses Development of Pan-Viral Drugs with AIkido PR Newswire NEW YORK , March 12, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company")...
The psychedelics story is gaining momentum, as NeonMind Biosciences ( CSE:NEON) (OTC:NMDBF), Lobe Sciences Ltd. (CSE:LOBE)(OTC:GTSIF), Mydecine Innovations Group (CSE:MYCO)(OTC:MYCOF), Aikido Pharma Inc. (NASDAQ:AIKI), and Seelos Therapeutics Inc. (NASDAQ:SEEL) race to h...
AIkido Pharma Inc. Updates Announcement of Webcast Link for the H.C. Wainwright Global Life Sciences Conference (Virtual Event) Investors can access the presentation on-demand starting at 7 a.m. ET on Tuesday, March 9, 2021 PR Newswire NEW YORK , March 4, 2021 ...
AIkido Pharma Inc. to Present at the H.C. Wainwright Global Life Sciences Conference (Virtual Event) PR Newswire NEW YORK , March 1, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced it will be featured as a p...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – February 25, 2021 – The emergence of psychedelics as a mental health solution and as a legitimate industry has been one of the most radical market developments that we have seen in d...
AIkido Pharma Inc. Announces Exercise of Option to Purchase Additional Shares in Bought Deal Offering PR Newswire NEW YORK , Feb. 23, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the underwriter of i...
News, Short Squeeze, Breakout and More Instantly...
AIkido Pharma Inc. Company Name:
AIKI Stock Symbol:
NASDAQ Market:
AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) PR Newswire NEW YORK , Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (the "Company") today announced that it has changed its name from AI...
AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes PR Newswire Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI NEW YORK , Nov. 28, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (...
AIkido Share Repurchase Continues PR Newswire NEW YORK , Oct. 6, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company's share repurchase program (the "Share Repurchase Program") authori...